Peter Hamley is a recognized leader in drug discovery, having spent 15 years at Sanofi, most recently as global head of External Innovation, Drug Discovery in Business Development. Prior to this, he led global high throughput medicinal chemistry, natural product and antibody drug conjugate departments across Germany, France, and the US, and he contributed to the advancement of many projects into clinical development across several therapeutic areas. He started his career at AstraZeneca leading medicinal chemistry teams in the respiratory and inflammation disease areas. Prior to a postdoctoral position at the University of Pennsylvania, he obtained his PhD from the University of Cambridge, and a BSc in Chemistry from Imperial College London. He also holds an MBA from the University of Bath. Over his career in big pharma, he was involved in hundreds of drug discovery projects, executed external partnerships and published numerous papers and patents including co-editing the textbook Small Molecule Medicinal Chemistry: Strategies and Technologies (Wiley).